The US Food and Drug Administration’s TEMPO Pilot Signals a New Regulatory Approach for AI-Enabled Medical Devices
The US Food and Drug Administration’s TEMPO Pilot Signals a New Regulatory Approach for AI-Enabled Medical Devices
Authors of this article:
Tejas S Athni, JMIR Correspondent
There are currently no tweets available for this article within the specified range.
